Progressive multifocal leukoencephalopathy overview

Progressive multifocal leukoencephalopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Progressive multifocal leukoencephalopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Progressive multifocal leukoencephalopathy overview On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Progressive multifocal leukoencephalopathy overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Progressive multifocal leukoencephalopathy overview
CDC on Progressive multifocal leukoencephalopathy overview
Progressive multifocal leukoencephalopathy overview in the news
Blogs on Progressive multifocal leukoencephalopathy overview
Progressive multifocal leukoencephalopathy
Risk calculators and risk factors for Progressive multifocal leukoencephalopathy overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Progressive multifocal leukoencephalopathy (PML), also known as progressive multifocal leukoencephalitis, is a rare and usually fatal viral disease that is characterized by progressive damage (-pathy) or inflammation (-itis) of the white matter (leuko-) of the brain (-encephalo-) at multiple locations (multifocal). It occurs almost exclusively in people with severe immune deficiency, e.g. transplant patients on immunosuppressive medications, or AIDS patients.

References

Template:WH Template:WS